Lipoprotein(a) metabolism in subjects at high risk of cardiovascular disease

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Heart disease is a major health burden. Despite best evidence-based treatments, residual risk remains high. Lp(a), a small protein in the blood, is a powerful causal risk factor for premature heart disease, but little is known about its physiology or metabolism. This study will provide vital knowledge into Lp(a) metabolism and the mechanisms by which two unique therapies lower Lp(a) levels. These insights may expand treatment choices for people at risk of heart disease.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $690,735.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular disease | cardiovascular disease prevention | genetic disorders | lipoprotein metabolism | pharmacological intervention | risk factors